United States · FDA National Drug Code directory
Quetiapine Extended Release
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50228-383_47ce17ad-f0c0-8ce7-e063-6294a90a7520
- Product NDC
- 50228-383
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Composition / generic term
- Quetiapine
- Labeler
- ScieGen Pharmaceuticals, Inc
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20171129
- Source listing expiry
- 20271231
Source-listed ingredients
- QUETIAPINE FUMARATE — 300 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50228-383-05) · 50228-383-05
- 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50228-383-30) · 50228-383-30
- 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50228-383-60) · 50228-383-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →